Citadel Advisors’s Meihua International Medical Technologies MHUA Stock Holding History

Citadel Advisors’s Portfolio MHUA Stock Details MHUA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-238	Closed	-$8.62K	–	13535
2025 Q3	$8.62K	Buy	+238	New	+$9.72K	﹤0.01%	12569
2025 Q2	–	Sell	-1,505	Closed	-$50.5K	–	14070
2025 Q1	$50.5K	Buy	+1,505	New	+$49.6K	﹤0.01%	12304
2024 Q1	–	Sell	-396	Closed	-$58.5K	–	15139
2023 Q4	$58.5K	Buy	396 +40	+11%	+$7.34K	﹤0.01%	11619
2023 Q3	$62.3K	Buy	+356	New	+$96.4K	﹤0.01%	11481
2023 Q2	–	Sell	-391	Closed	-$263K	–	14892
2023 Q1	$263K	Buy	+391	New	+$646K	﹤0.01%	9650

Citadel Advisors's MHUA Position: Q4 2025 in Review

Citadel Advisors sold out of Meihua International Medical Technologies (MHUA) in Q4 2025, closing a stake of 238 shares — an estimated $8.62K sold.

Citadel Advisors first reported a position in MHUA in Q1 2023 and held it in 5 quarters. The position peaked at $263K in Q1 2023. 0 funds tracked by Wall St. Rank hold MHUA as of Q4 2025.

Citadel Advisors reported no remaining Meihua International Medical Technologies position as of Q4 2025 after selling out during the quarter.
Citadel Advisors sold 238 Meihua International Medical Technologies shares in Q4 2025, an estimated $8.62K.
Citadel Advisors first reported a position in Meihua International Medical Technologies in Q1 2023 and held it in 5 quarters.
Citadel Advisors's Meihua International Medical Technologies position peaked at $263K in Q1 2023.
0 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.